Risk Management & Pharmacovigilance Summit 2014

The importance of pharmacovigilance emerged back in the 1960s when problems with thalidomide treatment arose. The negative effects of thalidomide led to the development of more structured drug regulations and control over drug use and development.

Join professionals from pharmaceutical companies such as Pfizer, Sanofi, AstraZeneca, Bayer, Abbott and others at the Risk Management & Pharmacovigilance Summit and discuss current regulations, safety surveillance and risk management plans. Uncover the experience of other industry professionals to help your company improve in terms of drug safety and risk governance.

Speakers
Anne Senez,Jørgen Matz,Henry Goebe,
Marcin Marciniak MD,Magnus Nord,and many more...